We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Novel Device Contributes to Positive Phlebotomy Experience

By LabMedica International staff writers
Posted on 30 May 2018
Print article
Image: The BD Vacutainer UltraTouch push button blood collection set (Photo courtesy of Becton Dickinson).
Image: The BD Vacutainer UltraTouch push button blood collection set (Photo courtesy of Becton Dickinson).
Phlebotomy is a necessary procedure that may be a source of pain, stress and anxiety for some patients. While smaller gauge needles are known to lessen patient discomfort, they are often associated with increases in hemolysis or longer tube fill times.

A push button blood collection set has been engineered to minimize patient discomfort during blood collection. This device was evaluated for blood collection and allows clinicians to use a smaller gauge for easier access to small, difficult veins, without compromising tube fill time and sample quality.

Scientists from BD Life Sciences (Franklin Lakes, NJ, USA) conducted two studies with 214 subjects to compare pain and anxiety regarding future phlebotomy with three devices. Another study with 52 subjects assessed hemolysis in specimens collected with the two devices; bench testing evaluated tube-filling times with these devices.

The investigators evaluated the effect of a 5-bevel, 25-gauge blood collection set (BCS) with ultra-thin wall cannula (BD Vacutainer UltraTouch Push Button BCS (UltraTouch) on patient pain and anxiety compared with two 3-bevel, thin-wall, 23-gauge BCSs (BD Vacutainer Safety-Lok (Safety-Lok) and Greiner Bio-One Vacuette (Greiner, Kremsmünster, Austria). Hemolysis was evaluated visually, by Hemolysis Index and hemolysis-sensitive indicators potassium (K) and lactate dehydrogenase (LDH).

In a direct comparison with the BD Vacutainer UltraTouch blood collection set and traditional 23-gauge blood collection wingsets, the 25-gauge UltraTouch push button blood collection set demonstrated a statistically significant, 40% decrease in patient perceptions of insertion pain and 47% decrease in overall pain during blood collection, respectively. In addition, the study showed that the 25-gauge UltraTouch blood collection set did not increase hemolysis or increase tube filling times, in comparison to a traditional 23-gauge blood collection set. There was no significant difference in anxiety regarding future phlebotomy. No increase was observed in Hemolysis Index, K or LDH. Tube-filling times were comparable for each device.

The authors concluded that the 25-gauge UltraTouch provided less overall pain compared with the 23-gauge Vacuette, less pain upon needle insertion than the 23-gauge Safety-Lok, and no compromise in specimen quality or flow rate. The study was originally published in the July 2017 issue of The Journal of Applied Laboratory Medicine and was recently updated by Becton Dickinson.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
New
PSA Test
Humasis PSA Card

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.